A comparison of response in the presence or absence of a delay in induction therapy with bortezomib, lenalidomide, and dexamethasone. - Schepers AJ; Jones AR; Reeves BN; Tuchman SA; Bates JS (Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2019)